NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 218 filers reported holding NEVRO CORP in Q3 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,316,400 | -7.4% | 109,000 | +9.0% | 0.91% | +0.1% |
| Q3 2022 | $4,660,000 | +35.8% | 100,000 | +27.8% | 0.90% | +28.2% |
| Q2 2022 | $3,431,000 | -5.1% | 78,277 | +56.6% | 0.71% | -25.0% |
| Q1 2022 | $3,617,000 | +27.5% | 50,000 | +42.9% | 0.94% | +19.9% |
| Q4 2021 | $2,837,000 | -18.7% | 35,000 | +16.7% | 0.78% | -21.8% |
| Q3 2021 | $3,491,000 | -44.6% | 30,000 | -21.1% | 1.00% | -42.1% |
| Q2 2021 | $6,300,000 | +12.9% | 38,000 | -5.0% | 1.73% | +8.8% |
| Q1 2021 | $5,580,000 | -63.4% | 40,000 | -54.5% | 1.59% | -64.8% |
| Q4 2020 | $15,233,000 | +60.8% | 88,000 | +29.4% | 4.53% | +56.4% |
| Q3 2020 | $9,472,000 | +5.7% | 68,000 | -9.3% | 2.90% | +8.0% |
| Q2 2020 | $8,960,000 | +124.1% | 75,000 | +87.5% | 2.68% | +52.4% |
| Q1 2020 | $3,999,000 | – | 40,000 | – | 1.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |